Combinatorial chemistry & high throughput screening最新文献

筛选
英文 中文
Deciphering and Predicting the Anti-Gastric Cancer Constituents of Actinidia eriantha Benth. Root via UPLC-Q-TOF-MS and In Vitro Mechanistic Validation. 猕猴桃抗胃癌成分的破译与预测。UPLC-Q-TOF-MS及体外机制验证。
IF 1.7 4区 医学
Combinatorial chemistry & high throughput screening Pub Date : 2026-10-21 DOI: 10.2174/0113862073500841260928113103
Tao Li, Bin Du, Shuang Liu, Jiale Mao, Yiping Ye, Houxing Lei, Shaochang Wu, Xiaoqin Zhang
{"title":"Deciphering and Predicting the Anti-Gastric Cancer Constituents of <i>Actinidia eriantha Benth.</i> Root <i>via</i> UPLC-Q-TOF-MS and <i>In Vitro</i> Mechanistic Validation.","authors":"Tao Li, Bin Du, Shuang Liu, Jiale Mao, Yiping Ye, Houxing Lei, Shaochang Wu, Xiaoqin Zhang","doi":"10.2174/0113862073500841260928113103","DOIUrl":"https://doi.org/10.2174/0113862073500841260928113103","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;The roots of Actinidia eriantha Benth. (AER) are a traditional herbal medicine of the She ethnic group in China, which has been clinically recognized for its significant anticancer effects, including those against liver cancer and gastric cancer. However, the mechanisms and components underlying the anti-gastric cancer effects of AER remain unclear.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;The components in the water extract of AER were analyzed using Liquid Chromatography- Mass Spectrometry (LC-MS) technology. A rat metabolic model was employed to further identify the absorbable components of AER that enter the body. Network pharmacology was then applied to predict the mechanisms of action of the components of AER that enter the body. Subsequently, the effects of AERcontaining serum on gastric cancer cell proliferation, migration, and invasion were evaluated using the SGC7901 gastric cancer cell system. The expression levels of genes related to cell proliferation, migration, and invasion were measured using quantitative real-time polymerase chain reaction(qPCR). Finally, Western Blot (WB) analysis was performed to determine the levels of Phosphatidylinositol 3-Kinase (PI3K), Protein Kinase B (AKT) total protein, and the levels of their phosphorylated proteins.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;LC-MS analysis revealed that AER primarily contains phenolic compounds, flavonoids, and triterpenoids. Network pharmacology results indicated that the potential anti-gastric cancer components of AER mainly fall into two categories: pentacyclic triterpenoids (including Asiatic acid, Arjunolic acid, Tormentic acid, and Actinidic acid) and flavonoid compounds (such as Naringenin, Epicatechin, and Catechin). The anti-gastric cancer mechanisms of these components are closely associated with the PI3K-AKT signaling pathway. Subsequent experimental results demonstrated that AERcontaining serum significantly inhibited the proliferation, migration, and invasion of SGC7901 gastric cancer cells. Further mechanistic studies revealed that AER-containing serum significantly downregulated the expression of cancer-related genes, including PI3K, AKT, Vascular Endothelial Growth Factor (VEGF), Cyclin D1, and mechanistic Target of Rapamycin (mTOR). Western blot analysis confirmed that AER-containing serum notably reduced the levels of PI3K and AKT proteins, as well as their phosphorylated forms, thereby inhibiting the proliferation, migration, and invasion abilities of gastric cancer cells. These findings suggest that the anti-gastric cancer effects of AER are closely associated with suppression of the PI3K-AKT signaling pathway, and that this pathway may serve as a key target mediating its pharmacological actions.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Discussion: &lt;/strong&gt;These findings provide a scientific rationale for the traditional use of AER and offer data support for its further pharmaceutical development and clinical application.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Our","PeriodicalId":10491,"journal":{"name":"Combinatorial chemistry & high throughput screening","volume":" ","pages":""},"PeriodicalIF":1.7,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Network Diffusion on a Multiscale Interactome Reveals Novel Herbal Candidates and Bioactive Compounds Converging on Shared Effectors in Anemia. 多尺度相互作用组的网络扩散揭示了新的草药候选物和生物活性化合物在贫血中的共同效应。
IF 1.7 4区 医学
Combinatorial chemistry & high throughput screening Pub Date : 2026-10-21 DOI: 10.2174/0113862073501736261005025542
Won-Yung Lee
{"title":"Network Diffusion on a Multiscale Interactome Reveals Novel Herbal Candidates and Bioactive Compounds Converging on Shared Effectors in Anemia.","authors":"Won-Yung Lee","doi":"10.2174/0113862073501736261005025542","DOIUrl":"https://doi.org/10.2174/0113862073501736261005025542","url":null,"abstract":"<p><strong>Introduction/objective: </strong>Anemia is a prevalent hematological disorder driven by heterogeneous mechanisms-iron deficiency, chronic inflammation, impaired erythropoiesis, and hemolysis-that single-target therapies often fail to address. We systematically prioritized candidate herbs and their active compounds for anemia using a multiscale interactome-based network pharmacology framework.</p><p><strong>Methods: </strong>Herb-compound-target data were aggregated from OASIS, DrugBank, TTD, and STITCH; anemia disease targets came from DisGeNET. We generated diffusion profiles using a biased random walk with restart on the tripartite multiscale interactome, and ranked herbs by cosine similarity to the anemia profile. Hypergeometric testing, GO/KEGG enrichment, compound-level subnetwork analysis, and HERB-based transcriptome validation followed.</p><p><strong>Results: </strong>The top 10 prioritized herbs-led by Swertiae Herba, Geranii Herba, and Salviae Miltiorrhizae Radix-were enriched in TNF/NF-κB, HIF-1, and JAK-STAT/PI3K-Akt pathways. Four high-ranking herbs and seven constituent compounds (e.g., swertiamarin, p-hydroxybenzoic acid, physcion, salvianolic acids A/B) had not previously been proposed as therapeutic candidates for anemia. Transcriptome validation of tanshinone IIA implicated the cell cycle, PI3KAkt, and FoxO pathways and recovered GDF15 and CXCL12.</p><p><strong>Discussion: </strong>Across all subnetworks, divergent compound-target architectures converged on shared downstream effectors (PLEC, ITGB4, ELANE, TNF), supporting a multi-target paradigm. Mechanistic profiles further suggested subtype relevance: swertiamarin to inflammation-associated anemia; p-hydroxybenzoic acid to telomere/bone-marrow-failure anemias; physcion/epicatechin to oxidative-stress and hemolytic anemias.</p><p><strong>Conclusion: </strong>The framework offers a reproducible route to nominating multi-target herbal therapeutics for anemia, identifying novel candidates that warrant experimental validation.</p>","PeriodicalId":10491,"journal":{"name":"Combinatorial chemistry & high throughput screening","volume":" ","pages":""},"PeriodicalIF":1.7,"publicationDate":"2026-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and Molecular Outcomes of Dabrafenib/Trametinib-Based Combination Therapy in Acquired BRAF V600E-Mutant NSCLC Following Tyrosine Kinase Inhibitor Resistance: A Preliminary Single-Center Retrospective Study. 达非尼/曲美替尼联合治疗获得性BRAF v600e突变型NSCLC酪氨酸激酶抑制剂耐药的临床和分子结局:一项初步的单中心回顾性研究
IF 1.7 4区 医学
Combinatorial chemistry & high throughput screening Pub Date : 2026-10-20 DOI: 10.2174/0113862073425230260817104335
Dan Xu, Fang Hao, Xia Liu, Xin Wang, Diansheng Zhong
{"title":"Clinical and Molecular Outcomes of Dabrafenib/Trametinib-Based Combination Therapy in Acquired BRAF V600E-Mutant NSCLC Following Tyrosine Kinase Inhibitor Resistance: A Preliminary Single-Center Retrospective Study.","authors":"Dan Xu, Fang Hao, Xia Liu, Xin Wang, Diansheng Zhong","doi":"10.2174/0113862073425230260817104335","DOIUrl":"https://doi.org/10.2174/0113862073425230260817104335","url":null,"abstract":"<p><strong>Introduction: </strong>Acquired BRAF V600E is an uncommon resistance mechanism after tyrosine kinase inhibitor (TKI) therapy in oncogene-driven non-small cell lung cancer (NSCLC), and the clinical value of dabrafenib/trametinib-based combination therapy remains unclear. This preliminary single-center retrospective study aimed to describe the clinical, molecular, radiological, and safety outcomes of dabrafenib/trametinib-based combination therapy in patients with acquired BRAF V600E-mutant NSCLC after TKI resistance.</p><p><strong>Methods: </strong>Patients with acquired BRAF V600E-mutant NSCLC after prior EGFR/ALK TKI therapy between December 2019 and September 2023 were retrospectively reviewed. Clinical characteristics, treatment outcomes, adverse events, radiological findings, and serial molecular profiles from plasma, tissue, or pleural effusion samples were collected.</p><p><strong>Results: </strong>Three eligible patients were identified. The observed progression-free survival after dabrafenib/trametinib combination therapy was 2.2, 7.1, and 14.5 months. Toxicity was heterogeneous, including clinically significant pyrexia, treatment interruption, grade 2 hematologic toxicities, and rapid clinical deterioration in one patient. Among two patients with baseline brain metastases, intracranial lesions remained radiologically controlled during the available followup; however, this finding was descriptive and should not be interpreted as a reliable control rate. Serial molecular testing showed BRAF V600E disappearance after progression in selected cases, suggesting molecular heterogeneity.</p><p><strong>Discussion: </strong>Acquired BRAF V600E mutation is a key secondary resistance mechanism after EGFR/ALK TKI therapy. Combining BRAF/MEK and EGFR/ALK inhibitors is a feasible strategy for these patients. However, the varied treatment outcomes and toxicities highlight the high clinical and molecular heterogeneity of this disease. Because of our extremely small sample size and retrospective design, larger prospective studies are needed to confirm these preliminary findings.</p><p><strong>Conclusion: </strong>Dabrafenib/trametinib-based combination therapy may show clinical activity in selected patients with acquired BRAF V600E-mutant NSCLC after TKI resistance. However, the extremely small sample size, heterogeneous outcomes, and clinically significant toxicities preclude definitive conclusions regarding efficacy or safety.</p>","PeriodicalId":10491,"journal":{"name":"Combinatorial chemistry & high throughput screening","volume":" ","pages":""},"PeriodicalIF":1.7,"publicationDate":"2026-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrative Network Pharmacology, Molecular docking and Experimental Validation Uncover the Mechanism of Detoxifying Fumigation and Washing Granules against Hemorrhoids. 综合网络药理学、分子对接及实验验证揭示祛毒熏洗颗粒剂治疗痔疮的作用机制。
IF 1.7 4区 医学
Combinatorial chemistry & high throughput screening Pub Date : 2026-10-12 DOI: 10.2174/0113862073485357260927072628
Zhi Chang, Xuhong Shao, Yuhua Li, Fang Zhang, Liwen Zeng, Wenbo Li, Meidong Si, Yaping Jiang, Ru Zhou
{"title":"Integrative Network Pharmacology, Molecular docking and Experimental Validation Uncover the Mechanism of Detoxifying Fumigation and Washing Granules against Hemorrhoids.","authors":"Zhi Chang, Xuhong Shao, Yuhua Li, Fang Zhang, Liwen Zeng, Wenbo Li, Meidong Si, Yaping Jiang, Ru Zhou","doi":"10.2174/0113862073485357260927072628","DOIUrl":"https://doi.org/10.2174/0113862073485357260927072628","url":null,"abstract":"<p><strong>Introduction: </strong>Hemorrhoids significantly impair the quality of life of patients, primarily manifesting as pain, bleeding, and prolapse. Detoxifying fumigation and washing granules (DFWG), a traditional Chinese medicine, have demonstrated potential for alleviating hemorrhoids; however, its underlying mechanisms of action have yet to be fully elucidated. This study aimed to investigate the putative active constituents and possible mechanisms of DFWG in the treatment of hemorrhoids.</p><p><strong>Methods: </strong>Active compounds in DFWG were identified through network pharmacology, and targets were screened using protein-protein interaction (PPI) network analysis. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed to identify core signaling pathways, and in vivo validation was conducted in a rat model of perianal edema.</p><p><strong>Results: </strong>Network pharmacology identified 328 active compounds and 1020 targets from DFWG, along with 314 hemorrhoid-related targets, yielding 46 overlapping targets. PPI analysis revealed 10 core targets, while GO and KEGG analyses indicated roles in regulating apoptosis and inflammation. Molecular docking results indicated that the binding energies between core target proteins and compounds were consistently below -5.0 kcal/mol. In vivo, DFWG reduced perianal swelling and rectoanal coefficient in model rats, lowered serum IL-1β, TNF-α, and IL-6, and suppressed p-NF-κB p65/NF-κB p65 expression in perianal tissues.</p><p><strong>Discussion: </strong>The findings of network pharmacology indicate that DFWG primarily alleviates hemorrhoidal symptoms by modulating key inflammatory mediators. This mechanism is further supported by the observed reduction in inflammatory responses in model rats, along with concurrent improvements in pathological manifestations.</p><p><strong>Conclusion: </strong>DFWG exerts protective effects against hemorrhoids in rats, likely by suppressing inflammation.</p>","PeriodicalId":10491,"journal":{"name":"Combinatorial chemistry & high throughput screening","volume":" ","pages":""},"PeriodicalIF":1.7,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149179894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the Protective Effect of Xiangsha Yangwei Pills on Alcohol-Induced Gastric Injury Using an Integrated Approach. 综合探讨香沙养胃丸对酒精性胃损伤的保护作用。
IF 1.7 4区 医学
Combinatorial chemistry & high throughput screening Pub Date : 2026-10-08 DOI: 10.2174/0113862073482825260917105544
Yuxiang Huang, Yang Zhou, Shuaijun Guo, Chengsi Wu, Xinru Shao, Chenlu Liu, Xinting Cui, Li Li, Hao Zang, Guangqing Xia
{"title":"Exploring the Protective Effect of Xiangsha Yangwei Pills on Alcohol-Induced Gastric Injury Using an Integrated Approach.","authors":"Yuxiang Huang, Yang Zhou, Shuaijun Guo, Chengsi Wu, Xinru Shao, Chenlu Liu, Xinting Cui, Li Li, Hao Zang, Guangqing Xia","doi":"10.2174/0113862073482825260917105544","DOIUrl":"https://doi.org/10.2174/0113862073482825260917105544","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Alcohol-induced gastric injury is a common clinical problem with few good preventive options. In this study, we examined whether Xiangsha Yangwei Pills (XS), a traditional herbal formula used for digestive issues, could protect against ethanol-induced gastric damage and sought to elucidate how it might work.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We combined network toxicology and network pharmacology to identify the main active compounds in XS and their potential biological targets. Two key components that emerged from this analysis, quercetin and borneol, were then examined using computational methods to predict their antioxidant activity-specifically their electron-acquisition ability and frontier orbital energy gaps. We also conducted in vitro experiments to directly test how well XS scavenges free radicals and chelates metal ions. For in vivo testing, we used a mouse model of alcohol-induced gastric injury and measured parameters such as gastric mucosal lesion severity, ulcer index scores, and total ulcer area to assess whether XS had a protective effect.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The network analysis identified nineteen central targets, many of which were antioxidant-related enzymes such as superoxide dismutase, catalase, and myeloperoxidase. Our computational results suggested that the main active compounds have strong antioxidant potential, which was supported by the in vitro findings, showing that XS effectively scavenges free radicals and chelates metal ions. In the animal model, administering XS beforehand significantly reduced gastric mucosal damage, reducing both ulcer scores and the affected area by more than 80%. At the molecular level, XS treatment increased the activity of the body's own antioxidant enzymes (superoxide dismutase, catalase) and reduced tissue levels of oxidative stress markers such as malondialdehyde and myeloperoxidase.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Discussion: &lt;/strong&gt;The integration of network toxicology and pharmacology revealed 19 overlapping targets, predominantly antioxidant enzymes, suggesting that the gastroprotective effect of XS is mechanistically mediated by mitigating oxidative stress. This computational prediction was empirically validated by the observed increase in superoxide dismutase and catalase activities and the reduction in malondialdehyde and myeloperoxidase levels in vivo. Notably, the high binding affinities of core components such as quercetin and borneol to key targets (e.g., AKT1, TNF, TP53) suggest that XS may exert synergistic, multi-target modulation beyond direct radical scavenging, potentially influencing cell survival and inflammatory pathways. These findings position XS as a promising multi-component strategy for managing alcohol-induced gastric injury, bridging traditional use with modern mechanistic evidence.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Overall, our findings show that XS offers strong protection against alcohol-induced gastric injury. The main mechanism","PeriodicalId":10491,"journal":{"name":"Combinatorial chemistry & high throughput screening","volume":" ","pages":""},"PeriodicalIF":1.7,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149179912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Danggui Shaoyao Powder Alleviates MAFLD by Regulating the AMPK/Nrf2/NF-κB Signaling Pathway. 当归少药散通过调节AMPK/Nrf2/NF-κB信号通路缓解MAFLD。
IF 1.7 4区 医学
Combinatorial chemistry & high throughput screening Pub Date : 2026-10-08 DOI: 10.2174/0113862073477943260930051022
Yaning Biao, Xinqiao Chu, Xingxing Gao, Dou Zhang, Ying Gu, Yafen Wang, Yixin Zhang
{"title":"Danggui Shaoyao Powder Alleviates MAFLD by Regulating the AMPK/Nrf2/NF-κB Signaling Pathway.","authors":"Yaning Biao, Xinqiao Chu, Xingxing Gao, Dou Zhang, Ying Gu, Yafen Wang, Yixin Zhang","doi":"10.2174/0113862073477943260930051022","DOIUrl":"https://doi.org/10.2174/0113862073477943260930051022","url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to investigate the mechanisms by which Danggui Shaoyao powder (DSP) treats metabolic dysfunction-associated fatty liver disease (MAFLD).</p><p><strong>Methods: </strong>The MAFLD rats were established by feeding a high-fat diet (HFD). After 12 weeks of modeling, DSP treatment was administered simultaneously with the modeling for 4 weeks. Parameters assessed included lipid metabolism, liver function, oxidative stress, inflammatory factors, and reactive oxygen species (ROS) levels. Hepatic histopathological changes were also evaluated. Proteins associated with the AMP-activated protein kinase (AMPK)/nuclear factor erythroid 2-related factor 2 (Nrf2)/nuclear factor-κB (NF-κB) signaling pathway were analyzed using western blot. Additionally, the involvement of the AMPK/Nrf2/NF-κB signaling pathway in palmitic acid (PA)-induced HepG2 cells was confirmed using an AMPK activator and AMPK and Nrf2 inhibitors.</p><p><strong>Results: </strong>Findings demonstrated that DSP effectively regulated lipid metabolism, improved liver function, and reduced oxidative injury and inflammation in MAFLD rats. In PA-treated HepG2 cells, DSP significantly decreased lipid accumulation, oxidative stress, and inflammation. Furthermore, DSP increased AMPK phosphorylation, leading to Nrf2 activation and inhibition of NF-κB phosphorylation in both MAFLD rats and HepG2 cells.</p><p><strong>Conclusion: </strong>The results indicate that DSP mitigates oxidative damage and inflammation associated with MAFLD, likely by modulating the AMPK/Nrf2/NF-κB signaling pathway.</p>","PeriodicalId":10491,"journal":{"name":"Combinatorial chemistry & high throughput screening","volume":" ","pages":""},"PeriodicalIF":1.7,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149179873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Safety of Acupoint Catgut Embedding Combined with Hormone Replacement Therapy versus Sham Acupoint Embedding Combined with Hormone Replacement Therapy for Diminished Ovarian Reserve: A Single-Blind Randomized Controlled Trial. 穴位埋线联合激素替代疗法与假穴位埋线联合激素替代疗法治疗卵巢储备功能减退的疗效和安全性:一项单盲随机对照试验。
IF 1.7 4区 医学
Combinatorial chemistry & high throughput screening Pub Date : 2026-10-08 DOI: 10.2174/0113862073473958260916111037
Yijin Zhang, Wei Sun, Jianting Lao, Yueping Wang, Jiahui Li, Yunlan Wang, Yao Wang, Hong Yang
{"title":"Efficacy and Safety of Acupoint Catgut Embedding Combined with Hormone Replacement Therapy versus Sham Acupoint Embedding Combined with Hormone Replacement Therapy for Diminished Ovarian Reserve: A Single-Blind Randomized Controlled Trial.","authors":"Yijin Zhang, Wei Sun, Jianting Lao, Yueping Wang, Jiahui Li, Yunlan Wang, Yao Wang, Hong Yang","doi":"10.2174/0113862073473958260916111037","DOIUrl":"https://doi.org/10.2174/0113862073473958260916111037","url":null,"abstract":"<p><strong>Introduction: </strong>To investigate the differences in efficacy between Hormone Replacement Therapy (HRT) combined with Acupoint Catgut Embedding (ACE) and HRT combined with Sham Acupoint Embedding (SAM) in patients with Diminished Ovarian Reserve (DOR).</p><p><strong>Methods: </strong>A prospective, multicenter, randomized, single blind, controlled trial design was employed. Participants were randomly allocated to either the HRT + ACE group or the HRT + SAM group. Active treatment lasted 3 menstrual cycles, followed by 3 cycles of follow-up. Serum AMH, AFC, Ovarian volume, and serum Testosterone (T), FSH, LH, Estradiol (E2), Prolactin (PRL), and Cytokines (IL-2, IL-6, IL-17) levels were measured pre-treatment and post 3- treatment cycles and at follow-up for 3 treatment cycles.</p><p><strong>Results: </strong>In the treatment group, after 3 treatment cycles, AMH levels increased from baseline (P < 0.05). AFC, ovarian volume, and E2 all increased significantly in both groups compared with baseline (P < 0.05). Basal FSH (bFSH), basal LH (bLH), and IL-2 levels significantly decreased in the two groups (P < 0.05). All indicators in the treatment group at both post-treatment and 3- month follow-up were significantly better than baseline (P < 0.05). The treatment group was better than the control group in terms of AMH, AFC, bFSH, bLH, and IL-2 after 3 months and 6 months follow-up (P < 0.05). No serious adverse events occurred in either group.</p><p><strong>Discussion: </strong>This study demonstrates that HRT combined with ACE can regulate neuroendocrine function, stimulate the reproductive axis, and modulate HPO axis function to improve ovarian function. Although ACE cannot normalize ovarian function, it optimizes follicle development and menstruation. It is a promising low-risk alternative for HRT-intolerant DOR patients.</p><p><strong>Conclusion: </strong>HRT combined with ACE can improve certain ovarian reserve indicators, including increasing AMH levels, AFC, and ovarian volume in DOR patients, with effects superior to those of HRT combined with SAM, suggesting that HRT combined with ACE may enhance ovarian function in DOR patients.</p>","PeriodicalId":10491,"journal":{"name":"Combinatorial chemistry & high throughput screening","volume":" ","pages":""},"PeriodicalIF":1.7,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149179906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study of the Mechanism of Xianglian Anchang Decoction Ameliorating Ulcerative Colitis Based on Transcriptomics and Network Pharmacology Analysis. 香连安肠汤改善溃疡性结肠炎机制的转录组学和网络药理学研究。
IF 1.7 4区 医学
Combinatorial chemistry & high throughput screening Pub Date : 2026-10-02 DOI: 10.2174/0113862073486769260919093835
Tianyu Gao, Cuimei Zhao, Lishan Lu, Ziyue Luo, Chen Wang, Junzhuo Ma, Xuetong Ren, Xiaosong Xu, Jiong Chen, Jingjing Lv, Shixiong Zhang, Qian Yang, Yangang Wang
{"title":"Study of the Mechanism of Xianglian Anchang Decoction Ameliorating Ulcerative Colitis Based on Transcriptomics and Network Pharmacology Analysis.","authors":"Tianyu Gao, Cuimei Zhao, Lishan Lu, Ziyue Luo, Chen Wang, Junzhuo Ma, Xuetong Ren, Xiaosong Xu, Jiong Chen, Jingjing Lv, Shixiong Zhang, Qian Yang, Yangang Wang","doi":"10.2174/0113862073486769260919093835","DOIUrl":"https://doi.org/10.2174/0113862073486769260919093835","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;The therapeutic efficacy of Xianglian Anchang Decoction (XLAC) in Ulcerative Colitis (UC) has been established, but the underlying pharmacological mechanisms have remained poorly elucidated. In this study, we employed an integrated strategy combining network pharmacology, transcriptomic profiling, and in vivo experimentation to reveal these mechanisms, with a particular focus on how XLAC modulates the IL-17/AP-1 signaling axis to attenuate intestinal inflammation and promote mucosal repair.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;UC was induced in mice by 2% Dextran Sulfate Sodium (DSS) administration in drinking water. The animals were randomly divided into five groups: control (untreated), model (DSS only), XLAC-L (12.4 g/kg/day XLAC extract), XLAC-H (24.8 g/kg/day XLAC extract), and sulfasalazine reference (SASP) (5 g/kg/day sulfasalazine reference drug). Following a 7-day treatment period, various parameters were evaluated, including body mass fluctuations, colon dimensions, microscopic tissue alterations, and intestinal barrier integrity biomarker levels. A computational target prediction analysis was performed to elucidate the pharmacological mechanisms of XLAC, with subsequent transcriptome sequencing verification. Analytical techniques including fluorescence-activated cell sorting, protein immunoblotting, and tissue staining were employed to investigate the modulatory impact of XLAC on UC via the IL-17/AP-1 molecular cascade. Molecular docking and molecular dynamics simulations were performed to evaluate constituent-target binding and complex stability.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;XLAC significantly prevented DSS-induced body weight loss, preserved colon length, and reduced the severity of colonic histopathological injury. The XLAC intervention suppressed the secretion of inflammatory mediators such as IL-6 and TNF-α, while concurrently promoting the expression of the tight junctional protein ZO-1. Integrated network pharmacology and transcriptomic profiling identified the IL-17 signaling pathway as a potential mechanism underlying the therapeutic effect of XLAC against UC. Further experiments validated that XLAC decreased IL-17A levels and inhibited both the expression and phosphorylation of the AP-1 transcription factors c-Jun and c-Fos. Molecular docking revealed stable binding between the principal bioactive constituents of XLAC (β-sitosterol and quercetin) and the c-Jun/c-Fos protein complex. Molecular dynamics simulations demonstrate the structural stability of the β-sitosterol-c-FOS complex.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Discussion: &lt;/strong&gt;Our findings reveal a critical role of the IL‑17/AP‑1 signaling axis in the pathogenesis of Ulcerative Colitis (UC) and demonstrate that XLAC may exert its therapeutic effects through this pathway. The multi‑target regulatory mechanism of XLAC provides a molecular basis for its superior efficacy and fewer side effects compared with conventional single‑target therapies. These data ","PeriodicalId":10491,"journal":{"name":"Combinatorial chemistry & high throughput screening","volume":" ","pages":""},"PeriodicalIF":1.7,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149165053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the Therapeutic Efficacy and Molecular Mechanisms of Fu-zheng-yi-qi Recipe in Ameliorating Cancer Cachexia-associated Muscle Atrophy. 扶正益气方改善癌症恶病质相关性肌萎缩的疗效及分子机制探讨。
IF 1.7 4区 医学
Combinatorial chemistry & high throughput screening Pub Date : 2026-10-02 DOI: 10.2174/0113862073496059260917104847
Guangran Hu, Xuan Li, Yinqiu Wu, Shengzhe Zhang, Guilan Jin, Ning Ding, Jun Zhang, Hua Dai
{"title":"Exploring the Therapeutic Efficacy and Molecular Mechanisms of Fu-zheng-yi-qi Recipe in Ameliorating Cancer Cachexia-associated Muscle Atrophy.","authors":"Guangran Hu, Xuan Li, Yinqiu Wu, Shengzhe Zhang, Guilan Jin, Ning Ding, Jun Zhang, Hua Dai","doi":"10.2174/0113862073496059260917104847","DOIUrl":"https://doi.org/10.2174/0113862073496059260917104847","url":null,"abstract":"<p><strong>Introduction: </strong>Cancer Cachexia (CC) is a systemic wasting syndrome characterized by persistent skeletal muscle depletion. This study aims to systematically evaluate the therapeutic effect of the Fu-zheng-yi-qi recipe (FZYQR) against CC and to explore the potential molecular mechanisms underlying its ameliorative effects on muscle atrophy.</p><p><strong>Methods: </strong>The components of FZYQR were characterized using UPLC-Class Plus/VION IMS QTof. Pharmacological network analysis was performed to predict the therapeutic targets of FZYQR. An in vivo tumor cachexia model was established by subcutaneously implanting C26 tumor cells into male BALB/c mice. The therapeutic efficacy of FZYQR was evaluated by monitoring changes in body weight, grip strength, skeletal muscle mass, pathological progression, blood biochemical parameters, and inflammatory cytokine levels. The therapeutic mechanism underlying muscle atrophy was validated by qPCR and Western blot.</p><p><strong>Results: </strong>Among the major bioactive components of FZYQR, luteolin and quercetin play critical roles in treating CC. FZYQR significantly ameliorated muscle atrophy and associated symptoms in a well-established mouse model of CC. Mechanistically, upon FZYQR intervention, the expression level of JUN in skeletal muscle tissues of cachectic mice was markedly inhibited, accompanied by downregulation of the muscle atrophy biomarkers Atrogin-1 and MuRF1.</p><p><strong>Discussion: </strong>The specific mechanism underlying CC-induced muscle atrophy remains to be further elucidated. This study demonstrates the therapeutic potential of FZYQR for CC, and also provides a research strategy for the future development of natural products with anti-muscle atrophy effects.</p><p><strong>Conclusion: </strong>FZYQR exerts protective effects against CC-induced muscle atrophy, potentially through the modulation of the JNK/c-Jun signaling pathway.</p>","PeriodicalId":10491,"journal":{"name":"Combinatorial chemistry & high throughput screening","volume":" ","pages":""},"PeriodicalIF":1.7,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149168540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metal Nanoparticles as Modulators of the NF-κB Signaling Pathway: Emerging Concepts in Inflammation Research. 金属纳米颗粒作为NF-κB信号通路的调节剂:炎症研究中的新兴概念。
IF 1.7 4区 医学
Combinatorial chemistry & high throughput screening Pub Date : 2026-09-29 DOI: 10.2174/0113862073516316260910115503
Suraj N Mali, Gerald H Lushington
{"title":"Metal Nanoparticles as Modulators of the NF-κB Signaling Pathway: Emerging Concepts in Inflammation Research.","authors":"Suraj N Mali, Gerald H Lushington","doi":"10.2174/0113862073516316260910115503","DOIUrl":"https://doi.org/10.2174/0113862073516316260910115503","url":null,"abstract":"<p><p>The NF-κB signaling pathway is a key regulator of inflammation and an attractive therapeutic target in inflammatory diseases. Metal nanoparticles (MNPs) have emerged as promising modulators of this pathway through mechanisms involving reactive oxygen species, IκBα degradation, p65 nuclear translocation, and crosstalk with MAPK, PI3K/AKT, JAK/STAT, Nrf2, and NLRP3 signaling. This editorial summarizes recent advances in the dual immunomodulatory roles of MNPs, highlighting how their composition, size, surface characteristics, and dose determine their pro- or anti-inflammatory effects.</p>","PeriodicalId":10491,"journal":{"name":"Combinatorial chemistry & high throughput screening","volume":" ","pages":""},"PeriodicalIF":1.7,"publicationDate":"2026-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149105197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书